Multimodal Imaging-Guided Stem Cell Ocular Treatment-Reference-Cited by-同舟云学术

Multimodal Imaging-Guided Stem Cell Ocular Treatment

Published:2024-05-27 Issue:23 Volume:18 Page:14893-14906
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Nguyen Van Phuc¹^ORCID,Karoukis Athanasios J.¹,Qian Wei²,Chen Lisheng¹,Perera Nirosha D.¹,Yang Dongshan³,Zhang Qitao¹,Zhe Josh¹,Henry Jessica¹,Liu Bing²,Zhang Wei⁴,Fahim Abigail T.¹,Wang Xueding⁴^ORCID,Paulus Yannis M.¹⁴^ORCID

Affiliation:

1. Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan 48105, United States

2. IMRA America Inc., Ann Arbor, Michigan 48105, United States

3. Center for Advanced Models for Translational Sciences and Therapeutics, University of Michigan, Ann Arbor, Michigan 48109, United States

4. Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48105, United States

Funder

International Retinal Research Foundation

University of Michigan

National Eye Institute

Research to Prevent Blindness

Alcon Research Institute

Doris Duke Charitable Foundation

Choroideremia Research Foundation

Helmut F. Stern Career Development Professorship in Ophthalmology and Visual Sciences

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c10632

Reference55 articles.

1. Updates on the Epidemiology of Age-Related Macular Degeneration

2. Molecular pathology of age-related macular degeneration

4. HTRA1 Promoter Polymorphism in Wet Age-Related Macular Degeneration

5. Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept